It's Worth It: The Use of Long-Acting Injectable Antipsychotics in Early Psychosis

Abstract

This presentation will enable participants to do the following: 1) review factors contributing to nonadherence in early psychosis in adolescents; 2) gain an understanding of the differences in pharmacokinetics in oral versus depot formulations of antipsychotic medications to guide clinical decision making; 3) become familiar with the evidence for the use of long-acting injectable (LAI) antipsychotic medications in first-episode psychosis; and 4) learn how to address systemic barriers for the use of LAIs in early psychosis.